team

UK’s Nurse Margaret Wins the Coveted Aster Guardians Global Nursing Award 2023

India, 15 May 2023: Margaret Helen Shepherd from UK has been announced as the winner of the Aster Guardians Global Nursing Award 2023 in a prestigious award ceremony held at Queen Elizabeth II Centre in London. The winner was announced by Dr. Azad Moopen, Founder Chairman and Managing Director of Aster DM Healthcare and the […]

UK’s Nurse Margaret Wins the Coveted Aster Guardians Global Nursing Award 2023 Read More »

14 year old boy with a rare disease of nerves Guillain Barre syndrome got new lease of life

15 May 2023: Wockhardt Hospitals Nagpur is a leading healthcare provider with a tradition of care and innovation that makes this hospital a boon for patients in Central India. Wockhardt Hospitals Nagpur , which handles critical patients, successfully treated yet another critically ill 14 year old boy. Wockhardt Hospitals Nagpur again proved their mettle and

14 year old boy with a rare disease of nerves Guillain Barre syndrome got new lease of life Read More »

Fortis Malar Hospital forms a grand human chain to celebrate International Nurses Day

Chennai, 12 May 2023: The nursing department of Fortis Malar Hospital, Adyar today formed a human chain to celebrate International Nurses Day and pay tribute to nurses who have always been on the forefront to duly perform their responsibilities with care, commitment, dedication, compassion, and kindness. The hospital’s staff actively took part in the formation

Fortis Malar Hospital forms a grand human chain to celebrate International Nurses Day Read More »

TechInvention launches Euvichol-Plus…

TechInvention launches Euvichol-Plus, the world’s first and only oral cholera vaccine in an LDPE unidose pack, in India May 2023: TechInvention Lifecare Pvt. Ltd., India, has partnered with M/s. Eubiologics Co., Ltd. (Eubiologics), South Korea, to launch Euvichol-Plus, the world’s first and only oral cholera vaccine (OCV), in a low-density polyethylene (LDPE) unidose pack in

TechInvention launches Euvichol-Plus… Read More »

Amway launches website in Tamil to bring health and wellness closer to its consumers

  Chennai, 11th May 2023: In its continuous efforts towards building a healthier nation by advocating the importance of holistic wellness and making its products more accessible for people, Amway India, one of the leading FMCG Direct Selling companies, breaks the language barrier by announcing the launch of its website in Tamil, one of the

Amway launches website in Tamil to bring health and wellness closer to its consumers Read More »

ICRI announced its partnership with PD Hinduja Hospital in Mumbai

ICRI India, a renowned institution for education and training in New Age Careers, has collaborated with PD Hinduja Hospital in Mumbai to offer a PG Diploma in Clinical Research & Data Science. This partnership enables ICRI India to utilize the hospital’s experienced Clinical Research professionals and state-of-the-art facilities to provide industry-relevant education and training to

ICRI announced its partnership with PD Hinduja Hospital in Mumbai Read More »

Takeda pledges support to HAE patients through its Sunrise patient support program

Mumbai, 10th May 2023: Takeda Biopharmaceuticals India Private Limited (formerly known as Baxalta Bioscience India Pvt. Ltd.), a global values-based, R&D-driven biopharmaceutical leader has launched its ‘Sunrise Patient Services Program (PSP)’ for Hereditary Angioedema (HAE) patients in India. HAE is a life-threatening rare genetic disease that affects various parts of the body, such as limbs,

Takeda pledges support to HAE patients through its Sunrise patient support program Read More »

Stempeutics Phase 3 Cell Therapy Trial for Diabetic Foot Ulcer Completes Patient Enrollment

Bengaluru, May 09, 2023: Stempeutics Research, a group company of Manipal Education and Medical Group (MEMG), announced today that enrollment has completed in the Phase 3 clinical trial evaluating a single peri-ulcer injection of its proprietary allogeneic mesenchymal stromal cell product candidate Stempeucel®-DFU in patients with Non-Healing Diabetic Foot Ulcer. Drug is administered through intramuscular

Stempeutics Phase 3 Cell Therapy Trial for Diabetic Foot Ulcer Completes Patient Enrollment Read More »